Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients (CANALI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02474420 |
|
Recruitment Status : Unknown
Verified October 2016 by Kevin H.M. Kuo, MD, MSc, FRCPC, University Health Network, Toronto.
Recruitment status was: Recruiting
First Posted : June 17, 2015
Last Update Posted : October 26, 2016
|
Sponsor:
Kevin H.M. Kuo, MD, MSc, FRCPC
Information provided by (Responsible Party):
Kevin H.M. Kuo, MD, MSc, FRCPC, University Health Network, Toronto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | June 2017 |
| Estimated Study Completion Date : | June 2018 |